close

Amrutanjan Health Care Ltd

Know More
NSEBSE

614.60-10.60 (-1.70%)

03:57 PM,28th Sep 2023

615.00-9.25 (-1.48%)

04:01 PM,28th Sep 2023

BSE : 590006

NSE : AMRUTANJAN

Sector : Health care

ISIN Code : INE098F01031

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Sep 28 2023 | 04:01 PM IST

Market Cap (₹ Cr)

1794

Turnover (₹ Cr)

0.17

Volume (Shares)

27701

Face Value

1

52-WK High

775.45

52-WK High Date

30 Jun 2023

52-WK Low

554.05

52-WK Low Date

31 Mar 2023

All Time High

1024.55

All Time High Date

08 Nov 2021

All Time Low

41.30

All Time Low Date

05 Nov 2009

Amrutanjan Health Care Ltd

The Madras-based Amrutanjan manufactures bulk drugs and drug intermediateslike theophylline based on in-house research. Three plants have been set up in the Alandur industrial belt near Madras to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops.Amrutanjan also has an agreement with a company in Philadelphia US to supply custom-made chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill Amrutanjan gripe water sans alcohol Amrutanjan Maha Strong etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 1996-97 it has introduced a new product called 'Cold Snap Gel' and also a mint called 'tingle'. Company having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Ltd having holding stake 99.80% & Amrutanjan Finance Ltd having holding stake is 57.26%.Company has taken efforts to increase the export of fine chemicals & also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover & net Profit of the Company.'Diakyur' for the treatment of Diabetes was introduced during 2000-2001 and it has been well accepted by the customers. The company's R & D has been engaged in the development of neutraceuticals.The company is mainly focussing on Bio-Tech products and expects a good results from this division. During 2001-02 the company allotted 1600000 equity bonus shares of Rs.10/- each and subsequently the share capital has increased from Rs.1.60 crores to Rs.3.20 crores.

Amrutanjan Health Care Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

1794

EPS - TTM (₹) [S]

14.77

P/E Ratio (X) [S]

6.18

Face Value (₹) 1
Latest Dividend (%)260.00
Latest Dividend Date 14 Sep 2023
Dividend Yield (%) 0.75
Book Value Share (₹) [S]99.48
P/B Ratio (₹) [S]6.18
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
DSP Small Cap Fund (G) 90.11 1466269 0.75
DSP Small Cap Fund (IDCW) 90.11 1466269 0.75
DSP Small Cap Fund - Direct (IDCW) 90.11 1466269 0.75
DSP Small Cap Fund - Direct (G) 90.11 1466269 0.75
Sundaram Small Cap Fund (IDCW) 29.78 484538 1.15
Sundaram Small Cap Fund (G) 29.78 484538 1.15
Sundaram Small Cap Fund - Direct (G) 29.78 484538 1.15
Sundaram Small Cap Fund - Direct (IDCW) 29.78 484538 1.15

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

611.00

629.80

Week Low/High

611.00

650.00

Month Low/High

606.55

660.00

Year Low/High

554.05

775.00

All time Low/High

5.05

1025.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-3.00%-3.05%-1.09-1.11%
1 Month0.74%0.64%0.791.13%
3 Month-8.01%-7.98%2.492.91%
6 Month3.42%3.25%13.7015.17%
1 Year-14.75%-14.86%15.7415.81%
3 Year41.71%41.55%72.4773.89%

Financials

Graph
Table

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
30-06-2023GRAVITON RESEARCH CAPITAL LLPNSEBUY191539737.21
30-06-2023GRAVITON RESEARCH CAPITAL LLPNSESELL191539737.86
10-06-2020GRAVITON RESEARCH CAPITAL LLPNSESELL152024391.52
10-06-2020GRAVITON RESEARCH CAPITAL LLPNSEBUY152024391.16
10-06-2020N.K.SECURITIESNSEBUY371237384.97
10-06-2020N.K.SECURITIESNSESELL371237385.33
28-07-2015RAJASHEKAR SWAMINATHAN IYERBSEBUY122500453.91
28-07-2015SECURITIES CAPITAL INV.LTDBSESELL122500453.85
26-11-2014RAJASHEKAR SWAMINATHAN IYERBSESELL80000461.52
26-11-2014SECURITIES CAPITAL INV.LTDBSEBUY80000461.52

Load More

Peer Group Comparison

NamePrice(In Rs)Chg(%)Mkt Cap(Rs Cr)Sales(Rs Cr)Profit(Rs Cr)EPS(Rs)P/E(x)

Shareholding Pattern

Jun 2023
Archive
CategoryShare(%)
Promoter50.04
Financial Institutions Banks0.09
Foreign Institutional Investors0.70
Insurance Companies0.00
Mutual Funds Uti6.93
Other Institutional Investors0.20
Indian Public35.03
Others Non Institutional Investors6.84
Custodians0.18

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

CMD & Executive Director : S Sambhuprasad

Independent Non Exe. Director : Marie Shiranee Pereira

Independent Non Exe. Director : V Raja

Independent Non Exe. Director : Muralidharan Swayambunathan

Independent Non Exe. Director : Meena Lochani Raghunathan

Non Executive Director : Ramaa Prabhakar Arikirevula

Company Sec. & Compli. Officer : M Srinivasan.

Registered Office: New 103 Old 42-45 LuzChurch Rd, Mylapore,Chennai,Tamil Nadu-600004 Ph: 91-44-24994164/24994465/24994366

Email:shares@amrutanjan.com

URL:http://www.amrutanjan.com